Skip to content
Events

Details

Listen in to learn the latest Illumina sequencing updates and innovations on the NovaSeq X and NextSeq 1000/2000 platforms. (16 min)

Lauren Fait

Lauren Fait
Executive Sequencing Specialist
Illumina

Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
7 Feb. 2024
10:30 AM
Presenter
Lauren Fait
Topic
Instruments, Sequencing reagents & flow cells, Software & informatics
Watch Now

Related Events

Oct 14
ASHG Annual Meeting 2025
Oct 14, 2025 – Oct 18, 2025
Explore Illumina innovations at ASHG 2025. Visit Illumina booth 1019 and join our sessions to advance your genomic research.
View Event
Nov 4
Illumina Innovation Days
Nov 4, 2025 – Dec 5, 2025
Join us as we discuss new innovative technology offerings from the Illumina product pipeline and introduce our newest system – the MiSeq i100 Series.
View Event
Nov 18
Pathogen sequencing made easy with the MiSeq i100
Nov 18, 2025
In this session, we’ll explore how the MiSeq™ i100 was built to support rapid, reliable sequencing for pathogen detection and microbial surveillance. This is a practical, under-the-hood look at how Illumina’s latest benchtop platform fits into real-world microbial workflows, not just in theory but in practice.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.